Medicinova (MNOV) Income from Continuing Operations (2010 - 2025)
Medicinova's (MNOV) quarterly Income from Continuing Operations came in at 2793526.0 in Q4 2025, up 8.55% year-on-year from 2573503.84 in Q4 2024, and up 13.1% on a QoQ basis from 3214575.0 in Q3 2025.
Medicinova (MNOV) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Medicinova (MNOV) has 16 years of Income from Continuing Operations data on file, last reported at 2793526.0 in Q4 2025.
- On a quarterly basis, Income from Continuing Operations rose 8.55% year-over-year to 2793526.0 in Q4 2025; TTM through Dec 2025 was 12871982.0, a 7.52% decrease from a year earlier, with the FY2025 full-year figure at 9473651.0, up 21.38% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 2793526.0, up from 3214575.0 in the prior quarter.
- Over the last five years, Income from Continuing Operations for MNOV reached as high as 226526.0 in Q1 2021 and fell as low as 85420679.0 in Q4 2023.
- Historically, Income from Continuing Operations has averaged 7232331.05 across 5 years, with a median of 3191373.5 in 2024.
- Across the five-year window, Income from Continuing Operations plunged 2745.49% in 2023 and soared 96.42% in 2024, its largest moves.
- Year by year, Income from Continuing Operations stood at 2099204.0 in 2021, then plunged by 43.0% to 3001966.0 in 2022, then plunged by 2745.49% to 85420679.0 in 2023, then surged by 96.42% to 3054687.0 in 2024, then grew by 8.55% to 2793526.0 in 2025.
- Per Business Quant data, the three most recent Income from Continuing Operations figures were 2793526.0 in Q4 2025, 3214575.0 in Q3 2025, and 3609146.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -37.09 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 227.36 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.68 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.03 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 727.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 362.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -453.82 Mn |
| 10 | Medicinova | 64.48 Mn | 64.48 Mn | 4,754.00 | -2.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -2.79 Mn |
| Sep 30, 2025 | -3.21 Mn |
| Jun 30, 2025 | -3.61 Mn |
| Mar 31, 2025 | -3.25 Mn |
| Dec 31, 2024 | -3.05 Mn |
| Sep 30, 2024 | -2.93 Mn |
| Jun 30, 2024 | -3.17 Mn |
| Mar 31, 2024 | -2.82 Mn |
| Dec 31, 2023 | -85.42 Mn |
| Sep 30, 2023 | -1.49 Mn |
| Jun 30, 2023 | -3.06 Mn |
| Mar 31, 2023 | -3.22 Mn |
| Dec 31, 2022 | -3.00 Mn |
| Sep 30, 2022 | -4.53 Mn |
| Jun 30, 2022 | -4.18 Mn |
| Mar 31, 2022 | -3.58 Mn |
| Dec 31, 2021 | -2.10 Mn |
| Sep 30, 2021 | -4.67 Mn |
| Jun 30, 2021 | -4.34 Mn |
| Mar 31, 2021 | -226,526.00 |